You searched for 'drugs':

Aducanumab is a drug that has been developed as a potential treatment for Alzheimer’s disease. Find out more about the drug, its path to approval in the US, and what it means for people with dementia in the UK.

There are 141 drugs being tested in clinical trials for the treatment of Alzheimer’s disease. 78% of these drugs are designed to try and slow down how quickly the disease progresses. We examine the three most promising drugs, lecanemab, donanemab and remternetug and summarise their journeys so far.

Our Drug Discovery programme is an exciting approach to developing treatments for dementia by 'repurposing' existing drugs.

Find out more about the work behind speeding up drug design.

We learn about a drug normally prescribed for people with diabetes that has been shown to reverse memory loss in mice that were bred to develop the symptoms of Alzheimer’s disease.

Find out how two existing drugs can block cell death in mice.

From our winter 2016 issue of Care and Cure magazine, find out more about research in mice that raises the possibility of a new treatment delivered by nasal spray.

From Care and cure magazine - Autumn 2015, find out about drug trial news from 2015.